26th Feb 2025 7:00 am |
RNS |
RTW CIO increases position to 15% |
25th Feb 2025 1:00 pm |
RNS |
Material purchase by CIO of the Investment Manager |
17th Feb 2025 7:00 am |
RNS |
Director/PDMR Shareholding |
14th Feb 2025 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
28th Jan 2025 7:00 am |
RNS |
Material Update from Portfolio Company |
27th Jan 2025 7:00 am |
RNS |
Kailera Reports Positive Data in Ph2 Obesity Trial |
17th Jan 2025 7:01 am |
RNS |
New Investment in Series A of Windward Bio |
17th Jan 2025 7:00 am |
RNS |
Additional Investment in Umoja Biopharma |
15th Jan 2025 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
14th Jan 2025 7:00 am |
RNS |
Additional Investment in Numab Therapeutics |
10th Jan 2025 7:00 am |
RNS |
New Investment in Series A of Alesta Therapeutics |
30th Dec 2024 7:00 am |
RNS |
CORXEL Announces Two Significant Transactions |
20th Dec 2024 12:15 pm |
RNS |
New Investment in Series A of Ottimo Pharma |
13th Dec 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
10th Dec 2024 12:00 pm |
RNS |
Holding(s) in Company |
10th Dec 2024 7:00 am |
RNS |
Appointment of Senior Independent Director |
15th Nov 2024 7:00 am |
RNS |
CORXEL Announces Acceptance of NDA for Aficamten |
14th Nov 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
1st Nov 2024 2:00 pm |
RNS |
New Investment in Series C Round of Evommune, Inc. |
1st Nov 2024 7:00 am |
RNS |
RTW Biotech Opportunities’ 5th Anniversary |
14th Oct 2024 6:12 pm |
RNS |
Monthly Valuation Update and Factsheet Replacement |
14th Oct 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
3rd Oct 2024 7:00 am |
RNS |
Launch of Obesity Company Kailera Therapeutics |
2nd Oct 2024 7:00 am |
RNS |
New Investment in Aktis Oncology |
27th Sep 2024 7:00 am |
RNS |
BioAge Labs completes $198 million IPO |
26th Sep 2024 7:00 am |
RNS |
GBP quote for the share class to cease |
16th Sep 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
13th Sep 2024 7:00 am |
RNS |
Half-year Report |
14th Aug 2024 7:01 am |
RNS |
Closed Period Notification |
14th Aug 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
6th Aug 2024 7:00 am |
RNS |
New Investment in Jade Biosciences, Inc |
22nd Jul 2024 12:00 pm |
RNS |
Artiva Biotherapeutics prices IPO at $167 million |
15th Jul 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
11th Jul 2024 7:00 am |
RNS |
Baroness Blackwood Appointed as Independent NED |
2nd Jul 2024 7:00 am |
RNS |
Investment in Mirador Therapeutics & Santa Ana Bio |
1st Jul 2024 7:00 am |
RNS |
Total Voting Rights |
14th Jun 2024 7:00 am |
RNS |
Monthly Valuation Update and Factsheet |
13th Jun 2024 7:00 am |
RNS |
Positive Data Announcement - Avidity Biosciences |
11th Jun 2024 7:00 am |
RNS |
Portfolio Company Numab Therapeutics Update |
5th Jun 2024 7:00 am |
RNS |
Transaction in Own Shares |